Abstract
Ageing is still a frequent limiting factor for aggressive treatments in patients with advanced head and neck squamous cell carcinoma (HNSCC). Some studies reported poor or no benefits from concurrent chemotherapy and radiotherapy (CTRT) in such patients, probably because of increased co-morbidities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
